Disease | myelofibrosis |
Symptom | C0027022|myeloproliferative disease |
Sentences | 1 |
PubMedID- 20801055 | We have studied tgfbeta1 levels in philadelphia-negative (ph-) myeloproliferative diseases, evaluating patients with primary myelofibrosis (pmf) that is characterized by increased numbers of circulating progenitor cells and bone marrow (bm) fibrosis, and patients with polycythemia vera (pv) or essential thrombocythemia (et) that do not present bm fibrosis. |
Page: 1